Fig. 1
From: AXL is a potential therapeutic target in dedifferentiated and pleomorphic liposarcomas
AXL and its ligand, GAS6, are highly expressed in DDLPS and PLS. a AXL expression was assessed by IHC analysis of TMAs containing NF samples and WDLPS, DDLPS, and PLS tumor samples (representative images are shown, 200× magnification). b Western blot analyses of TAM RTKs in panels of DDLPS and PLS cell lines. c GAS6 secretion was measured by ELISA in conditioned media for the indicated DDLPS and PLS cell lines. The data are means with SEMs for triplicate experiments (* = p < 0.05)